| Literature DB >> 25277969 |
Alexander D Miras1, Florian Seyfried, Alkystis Phinikaridou, Marcelo E Andia, Ioannis Christakis, Alan C Spector, René M Botnar, Carel W le Roux.
Abstract
OBJECTIVE: To determine whether rats reaching the same body mass, having been fed either a low-fat (LFD) or a high-fat diet (HFD), differ in white adipose tissue (WAT) deposition.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25277969 PMCID: PMC5644822 DOI: 10.1159/000368622
Source DB: PubMed Journal: Obes Facts ISSN: 1662-4025 Impact factor: 3.942
Diet composition
| Macronutrient and detailed composition | % of total energy contribution | |
|---|---|---|
| HFD | LFD | |
|
| 17.0 | 17.5 |
| Lysine | 1.0 | 0.7 |
| Methionine | 0.6 | 0.2 |
| Cystine | 0.1 | 0.2 |
| Threonine | 0.5 | 0.5 |
| Tryptophan | 0.1 | 0.2 |
| Arginine | 1.0 | 0.9 |
| Histidine | 0.3 | 0.4 |
| Isoleucine | 0.6 | 0.5 |
| Leucine | 1.0 | 1.0 |
| Phenylalanine | 0.6 | 0.7 |
| Valine | 0.7 | 0.7 |
| Alanine | 1.0 | 0.2 |
| Aspartic acid | 1.0 | 0.7 |
| Glutamic acid | 2.3 | 3.2 |
| Glycine | 1.7 | 1.1 |
| Proline | 1.6 | 1.2 |
| Serine | 0.7 | 0.6 |
| Tyrosine | 0.4 | 0.5 |
|
| ||
|
| 23.0 | 75.1 |
| Mono and disaccharides | 19.6 | 4.9 |
|
| ||
|
| 60 | 7.4 |
| Saturated fatty acids | ||
| C-10:0 capric acid | 0.6 | n/a |
| C-12:0 lauric acid | 0.6 | 0.0 |
| C-14:0 myristic acid | 0.3 | 0.1 |
| C-15:0 pentadecanic acid | 0.2 | n/a |
| C-16:0 palmitic acid | 16.4 | 0.3 |
| C-18:0 stearic acid | 8.6 | 0.01 |
| Monounsaturated fatty acids | ||
| C-16:1 palmitoleic acid | 1.7 | 0.1 |
| C-18:1 oleic acid | 19.2 | 0.8 |
| Polyunsaturated fatty acids | ||
| C-18:2 linoleic acid | 5.2 | 0.7 |
| C-18:3 linolenic acid | 0.3 | 0.1 |
| C-20:2 eicosadienoic acid | 0.2 | n/a |
| C-20:4 arachidonic acid | 0.0 | 0.1 |
The table shows the percentage energy contribution of the nutrients in the two diets used in the two experiments
Fig. 1Curves of the body mass for the HFD (squares) fed and LFD fed (circles) rat groups along the duration of experiment 1 (A, n = 11 per group) and experiment 2 (B, n = 10 per group). Levels of significance: *p < 0.05 **p < 0.01, NS = not significant.
Summary of results*
| Experiment 1 | Experiment 2 | Overall p value | |||||
|---|---|---|---|---|---|---|---|
| HFD1 group (n = 11) | LFD1 group (n = 11) | p value | HFD2 group (n = 10) | LFD2 group (n = 10) | p value | ||
| Starting body mass, g | 320.4 ± 3.1 | 346.2 ± 2.5 | <0.0001 | 326.4 ± 4.4 | 324.6 ± 3.9 | 0.76 | <0.0001 |
|
| |||||||
| Final body mass, g | 544.2 ± 8.6 | 538.5 ± 3.3 | 0.58 | 527.9 ± 11.8 | 534.6 ± 12 | 60.70 | 0.70 |
|
| |||||||
| Absolute increase in body mass, g | 223.8 ± 9.9 | 192.3 ± 5.7 | 0.01 | 201.5 ± 8.0 | 210.0 ± 9.2 | 0.50 | 0.06 |
| Relative increase in body mass, % of starting mass | 70.1 ± 3.4 | 55.6 ± 1.8 | 0.001 | 61.6 ± 1.9 | 64.5 ± 2.2 | 0.33 | 0.002 |
|
| |||||||
| Caloric intake, kcal/day | 125.1 ± 2.0 | 113.4 ± 1.8 | 0.002 | 132.0 ± 3.2 | 118.7 ± 2.9 | 0.007 | <0.001 |
|
| |||||||
| Final total WAT, g (quantified with MRI) | 121.2 ± 11.7 | 104.7± 8.0 | 0.33 | 136.3 ± 11.0 | 119.9 ± 7.7 | 0.19 | 0.07 |
|
| |||||||
| Final retroperitoneal and epididymal WAT, g (quantified with dissection) | 22.5 ± 1.4 | 18.6 ± 1.2 | 0.07 | 25.2 ± 1.1 | 21.4 ± 1.8 | 0.06 | 0.008 |
|
| |||||||
| Final plasma leptin levels, ng/ml | 7.4 ± 0.5 | 7.1 ± 0.4 | 0.57 | 8.9 ± 0.9 | 7.5 ± 1.0 | 0.29 | 0.21 |
The table summarises the main results of experiments 1 and 2. Data are expressed as mean ± standard error of the mean (SEM).
As indicated by superscript letters, statistical comparisons have been performed between the 2 groups within experiments 1 and 2 using
unpaired t tests or
a one-way ANOVA or
ANCOVA with final total body mass as the covariate and post hoc pair-wise Bonferonni corrected testing.
Subscripts: 1-from experiment 1, 2-from experiment 2.